100 related articles for article (PubMed ID: 2023630)
21. Effect of propylthiouracil-induced hypothyroidism on the onset of skeletal muscle necrosis in dystrophin-deficient mdx mice.
McArdle A; Helliwell TR; Beckett GJ; Catapano M; Davis A; Jackson MJ
Clin Sci (Lond); 1998 Jul; 95(1):83-9. PubMed ID: 9662489
[TBL] [Abstract][Full Text] [Related]
22. Effects of contractile activity on muscle damage in the dystrophin-deficient mdx mouse.
McArdle A; Edwards RH; Jackson MJ
Clin Sci (Lond); 1991 Apr; 80(4):367-71. PubMed ID: 1851074
[TBL] [Abstract][Full Text] [Related]
23. Dystrophin acts as a transplantation rejection antigen in dystrophin-deficient mice: implication for gene therapy.
Ohtsuka Y; Udaka K; Yamashiro Y; Yagita H; Okumura K
J Immunol; 1998 May; 160(9):4635-40. PubMed ID: 9574572
[TBL] [Abstract][Full Text] [Related]
24. Ringo, a Golden Retriever Muscular Dystrophy (GRMD) dog with absent dystrophin but normal strength.
Ambrósio CE; Valadares MC; Zucconi E; Cabral R; Pearson PL; Gaiad TP; Canovas M; Vainzof M; Miglino MA; Zatz M
Neuromuscul Disord; 2008 Nov; 18(11):892-3. PubMed ID: 18667316
[No Abstract] [Full Text] [Related]
25. Age-related changes in muscle calcium content in dystrophin-deficient mdx mice.
Reeve JL; McArdle A; Jackson MJ
Muscle Nerve; 1997 Mar; 20(3):357-60. PubMed ID: 9052816
[No Abstract] [Full Text] [Related]
26. Analysis of dystrophin in fast- and slow-twitch skeletal muscles from mdx and dy2J mice at different ages.
Anderson JE; Kao L; Bressler BH; Gruenstein E
Muscle Nerve; 1990 Jan; 13(1):6-11. PubMed ID: 2183046
[TBL] [Abstract][Full Text] [Related]
27. Overexpression of dystrophin in transgenic mdx mice eliminates dystrophic symptoms without toxicity.
Cox GA; Cole NM; Matsumura K; Phelps SF; Hauschka SD; Campbell KP; Faulkner JA; Chamberlain JS
Nature; 1993 Aug; 364(6439):725-9. PubMed ID: 8355788
[TBL] [Abstract][Full Text] [Related]
28. A comparative freeze-fracture study of plasma membrane of dystrophic skeletal muscles in dy/dy mice with merosin (laminin 2) deficiency and mdx mice with dystrophin deficiency.
Shibuya S; Wakayama Y; Oniki H; Kojima H; Saito M; Etou T; Nonaka I
Neuropathol Appl Neurobiol; 1997 Apr; 23(2):123-31. PubMed ID: 9160897
[TBL] [Abstract][Full Text] [Related]
29. [Expression of the human dystrophin gene in mdx mouse skeletal muscles after ballistic transfection].
Zelenin AV; Tarasenko OV; Kolesnikov VA; Mikhaĭlov VM; Kiselev AV; Baranov AN; Zelenina IA; Shafei RA; Ivashchenko TE; Evgrafov OV
Genetika; 1998 Jun; 34(6):730-6. PubMed ID: 9719921
[TBL] [Abstract][Full Text] [Related]
30. Normal cochlear function in mdx and mdx(Cv3) Duchenne muscular dystrophy mouse models.
Pillers DA; Duncan NM; Dwinnell SJ; Rash SM; Kempton JB; Trune DR
Laryngoscope; 1999 Aug; 109(8):1310-2. PubMed ID: 10443839
[TBL] [Abstract][Full Text] [Related]
31. Genetic correction of dystrophin deficiency and skeletal muscle remodeling in adult MDX mouse via transplantation of retroviral producer cells.
Fassati A; Wells DJ; Sgro Serpente PA; Walsh FS; Brown SC; Strong PN; Dickson G
J Clin Invest; 1997 Aug; 100(3):620-8. PubMed ID: 9239410
[TBL] [Abstract][Full Text] [Related]
32. Adeno-associated virus vector-mediated gene transfer into dystrophin-deficient skeletal muscles evokes enhanced immune response against the transgene product.
Yuasa K; Sakamoto M; Miyagoe-Suzuki Y; Tanouchi A; Yamamoto H; Li J; Chamberlain JS; Xiao X; Takeda S
Gene Ther; 2002 Dec; 9(23):1576-88. PubMed ID: 12424610
[TBL] [Abstract][Full Text] [Related]
33. Further aspects of muscular dystrophy in mdx mice.
Pastoret C; Sebille A
Neuromuscul Disord; 1993; 3(5-6):471-5. PubMed ID: 8186696
[TBL] [Abstract][Full Text] [Related]
34. alpha-Methylprednisolone promotes skeletal myogenesis in dystrophin-deficient and control mouse cultures.
Metzinger L; Passaquin AC; Warter JM; Poindron P
Neurosci Lett; 1993 Jun; 155(2):171-4. PubMed ID: 8377947
[TBL] [Abstract][Full Text] [Related]
35. In situ hybridisation of a Y chromosome-specific probe to male myoblasts after implantation into female skeletal muscle.
Coulton G; Skynner M; Pagel C; Morgan J; Partridge T
Biochem Soc Trans; 1991 Apr; 19(2):195S. PubMed ID: 1889574
[No Abstract] [Full Text] [Related]
36. Dystrophin is required for normal thin filament-membrane associations at myotendinous junctions.
Tidball JG; Law DJ
Am J Pathol; 1991 Jan; 138(1):17-21. PubMed ID: 1987762
[TBL] [Abstract][Full Text] [Related]
37. Dystrophin knockdown mice suggest that early, transient dystrophin expression might be enough to prevent later pathology.
Duan D
Neuromuscul Disord; 2008 Nov; 18(11):904-5. PubMed ID: 18818078
[TBL] [Abstract][Full Text] [Related]
38. The change in dystrophin phenotype in heterozygous mdx mice.
Pagel C; Watt D; Naudeer S; Partridge T; Morgan J
J Neuropathol Exp Neurol; 1991 May; 50(3):278-80. PubMed ID: 2022969
[No Abstract] [Full Text] [Related]
39. Prostaglandin metabolism in dystrophin-deficient MDX mouse muscle.
McArdle A; Foxley A; Edwards RH; Jackson MJ
Biochem Soc Trans; 1991 Apr; 19(2):177S. PubMed ID: 1889562
[No Abstract] [Full Text] [Related]
40. Dystrophin-deficient muscular dystrophy in an Alaskan malamute.
Ito D; Kitagawa M; Jeffery N; Okada M; Yoshida M; Kobayashi M; Nakamura A; Watari T
Vet Rec; 2011 Jul; 169(5):127. PubMed ID: 21730032
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
